Transplantations: Clinical Data
| Characteristic . | CY/GM/BM . | MAC/G/PB . | CY/G/PB . |
|---|---|---|---|
| Mobilization* | |||
| Time to WBC >700-1,000 | 3-19; 15 | 13-35; 18 | 9-19; 16 |
| CD34+ × 106 cells/kg | Not done | 2.1-114; 5.8 | 1.5-7; 3.8 |
| CFC (× 104)/kg | 2.3-145; 6.7 | 2.7-161; 38 | 12-85; 61 |
| LTC-IC (× 103)/kg | 0.35-12; 5.4 | 0.5-21; 3.2 | 1-10; 6 |
| Transplantation | |||
| Time to engraftment* | |||
| WBC | 9-33; 13 | 9-18; 11 | 2-11; 10 |
| Platelet | 12->100; 37 | 15-49; 21 | 15-21; 19 |
| RBC | 22->100; 41 | 16-51; 30 | 25-46; 29 |
| Survival† | |||
| 1-year survival | 80% (60%-100%) | 86% (68%-100%) | NA |
| Characteristic . | CY/GM/BM . | MAC/G/PB . | CY/G/PB . |
|---|---|---|---|
| Mobilization* | |||
| Time to WBC >700-1,000 | 3-19; 15 | 13-35; 18 | 9-19; 16 |
| CD34+ × 106 cells/kg | Not done | 2.1-114; 5.8 | 1.5-7; 3.8 |
| CFC (× 104)/kg | 2.3-145; 6.7 | 2.7-161; 38 | 12-85; 61 |
| LTC-IC (× 103)/kg | 0.35-12; 5.4 | 0.5-21; 3.2 | 1-10; 6 |
| Transplantation | |||
| Time to engraftment* | |||
| WBC | 9-33; 13 | 9-18; 11 | 2-11; 10 |
| Platelet | 12->100; 37 | 15-49; 21 | 15-21; 19 |
| RBC | 22->100; 41 | 16-51; 30 | 25-46; 29 |
| Survival† | |||
| 1-year survival | 80% (60%-100%) | 86% (68%-100%) | NA |